CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-24 | Parsey Merdad Chief Medical Officer | Grant or award | +29,644 | 56,772 | ||
| 2023-01-24 | Parsey Merdad Chief Medical Officer | Grant or award | +43,715 | 100,487 | ||
| 2023-01-24 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −17,749 | $84.02 | $1.5M | 82,738 |
| 2023-01-24 | Wilfong Diane E. SVP, Controller & CAO | Grant or award | +1,784 | 27,855 | ||
| 2023-01-24 | Wilfong Diane E. SVP, Controller & CAO | Grant or award | +4,100 | 31,955 | ||
| 2023-01-24 | Wilfong Diane E. SVP, Controller & CAO | Shares withheld for taxes | −1,244 | $84.02 | $105K | 30,711 |
| 2022-12-30 | Parsey Merdad Chief Medical Officer | Sale | −553 | $85.33 | $47K | 45,556 |
| 2022-12-29 | Lofton Kevin E Director | Grant or award · Phantom Stock | +26.35 | 3,103.77 | ||
| 2022-12-10 | Wilfong Diane E. SVP, Controller & CAO | Option exercise | +318 | 28,651 | ||
| 2022-12-10 | Wilfong Diane E. SVP, Controller & CAO | Shares withheld for taxes | −149 | $87.97 | $13K | 28,502 |
| 2022-12-10 | Wilfong Diane E. SVP, Controller & CAO | Option exercise · Restricted Stock Unit | −318 | 12,924 | ||
| 2022-12-10 | Parsey Merdad Chief Medical Officer | Option exercise | +1,039 | 46,595 | ||
| 2022-12-10 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −486 | $87.97 | $43K | 46,109 |
| 2022-12-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −1,039 | 44,101 | ||
| 2022-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +3,300 | 256,178 | ||
| 2022-12-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −1,542 | $87.97 | $136K | 254,636 |
| 2022-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −3,300 | 127,413 | ||
| 2022-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +990 | 40,893 | ||
| 2022-12-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −463 | $87.97 | $41K | 40,430 |
| 2022-12-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −990 | 50,308 |
Page 39 of 43 · 851 trades